Subjective, psychomotor, and physiological effects of cumulative doses of opioid μ agonists in healthy volunteers

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1454-1464

  Walker, Diana J ^a   Zacny, James P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; OPIATE AGONIST; PETHIDINE;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE; BREATHING RATE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIOSIS; MOOD; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PRURITUS; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA;

ADULT; AFFECT; ANALYSIS OF VARIANCE; ATTITUDE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYDROMORPHONE; INJECTIONS, INTRAVENOUS; MALE; MEPERIDINE; MORPHINE; NARCOTICS; PLACEBOS; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; RECEPTORS, OPIOID, MU; REFERENCE VALUES; RESPIRATION; TIME FACTORS;

EID: 0033022768     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders-IV. American Psychiatric Association, Washington, D.C.
2. Baddeley AD (1968) A three-minute reasoning test based on grammatical transformation. Psychonomic Sci 10:341-342.
3. Batterman RC (1943) Clinical effectiveness and safety of a new synthetic analgesic drug, demerol. Arch Intern Med 71:345-356.
4. Clark R, Schlinger H and Poling A (1990) Discriminative stimulus properties of phenytoin in the pigeon: Determination via a cumulative dosing procedure. Pharmacol Biochem Behav 35:537-541.
5. Clark RF, Wei EM and Anderson PO (1995) Meperidine: Therapeutic use and toxicity. J Emerg Med 13:797-802.
6. Derogatis LR, Lipman RS and Cozi L (1973) HSCL-90: An outpatient psychiatric rating scale-a preliminary report. Psychopharmacol Bull 9:13-17.
7. de Wit H, Pierri J and Johanson CE (1989) Assessing individual differences in ethanol preference using a cumulative dosing procedure. Psychopharmacology 98:113-119.
8. Fraser HF, van Horn GD, Martin WR, Wolbach AB and Isbell H (1961) Methods for evaluating addiction liability, (a) "attitude" of opiate addicts toward opiate-like drugs, (b) a short-term "direct" addiction test. J Pharmacol Exp Ther 133:371-387.
9. Gauvin DV, Briscoe RJ, Baird TJ, Vallett M, Carl KL and Holloway FA (1997) Cumulative vs. acute dose-response procedures produce differential BAC and behavioral functions for ethanol. Pharmacol Biochem Behav 57:397-403.
10. Haertzen CA (1966) Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol Rep 18:163-194.
11. Hannington-Kiff JG (1970) Measurement of recovery from outpatient general anaesthesia with a simple ocular test. Br Med J 3:132-135.
12. Jaffe JH and Martin WR (1990) Opioid analgesics and antagonists, in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th ed (Gilman AG, Rall TW, Nies AS and Taylor P eds) pp 485-521, Pergamon Press, New York.
13. Jasinski DR, Griffith JD, Pevnick J, Gorodetzky C, Cone E and Kay D (1977) Progress report from the clinical pharmacology section of the National Institute on Drug Abuse Addiction Research Center, pp. 133-168, U. S. Dept. of Health, Education, and Welfare.
14. Jasinski DR and Nutt JG (1973) Progress report on the clinical assessment program of the Addiction Research Center, pp. 108-130, U. S. Dept. of Health, Education, and Welfare.
15. Jasinski DR and Preston KL (1986) Evaluation of tilidine for morphine-like subjective effects and euphoria. Drug Alcohol Depend 18:273-292.
16. Lasagna L, von Felsinger JM and Beecher JK (1955) Drug-induced mood changes in man. 1. Observations on healthy subjects, chronically ill patients, and "postaddicts." JAMA 157:1006-1020.
17. Manner T, Kanto J and Salonen M (1987) Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers. Eur J Clin Pharmacol 31:673-676.
18. Mansky PA (1978) Opiates: Human psychopharmacology, in Handbook of Psychopharmacology, Vol. 12: Drugs of Abuse (Iversen LL, Iversen SD and Snyder SH eds) pp 95-185, Plenum Press, New York.
19. Martin WR, Sloan JW, Sapira JD and Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258.
20. McMillan DE, Cole-Fullenwider DA, Hardwick WC and Wenger GR (1982) Phencyclidine discrimination in the pigeon using color tracking under second-order schedules. J Exp Anal Behav 37:143-147.
21. Medical Economics Data Production (1996) Physicians' Desk Reference, 50th ed. Medical Economics Data Production, Montvale, NJ.
22. Nuotto EJ and Korttila K (1991) Evaluation of a new computerized psychomotor test battery: Effects of alcohol. Pharmacol Toxicol 68:360-365.
23. Oliveto AH, Bickel WK, Kamien JB, Hughes JR and Higgins ST (1994) Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology 114:417-423.
24. Parrott AC ( 1986) The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance. Psychopharmacology 89:347-354.
25. Pickworth WB, Rohrer MS and Fant RV (1997) Effects of abused drugs on psychomotor performance. Exp Clin Psychopharmacol 3:235-241.
26. Preston KL and Bigelow GE (1993) Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers. J Pharmacol Exp Ther 264: 813-823.
27. Preston KL and Bigelow GE (1994) Drug discrimination assessment of agonist-antagonist opioids in humans: A three-choice saline-hydromorphone-butorphanol procedure. J Pharmacol Exp Ther 271:48-60.
28. Preston KL, Bigelow GE and Liebson IA (1989) Antagonist effects of nalbuphine in opioid-dependent human volunteers. J Pharmacol Exp Ther 248:929-937.
29. Rapp SE, Egan KJ, Ross BK, Wild LM, Terman GW and Ching JM (1996) A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesth Analg 82:1043-1048.
30. Reisine T and Pasternak G (1996) Opioid analgesics and antagonists, in Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 9th ed (Hardman JG, Gilman AG and Limbird LE eds) pp 521-555, Pergamon Press, New York.
31. Sannita WG, Maggi L and Rosadini G (1987) Effects of scopolamine (0.25-0.75 mg i.v.) on the quantitative EEG and the neuropsychological status of healthy volunteers. Neuropsychobiology 17:199-205.
32. Seevers MH and Pfeiffer CC (1936) A study of the analgesia, subjective depression, and euphoria produced by morphine, heroine, dilaudid and codeine in the normal human subject. J Pharmacol Exp Ther 56:166-187.
33. Selzer ML (1971) The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am J Psychiatry 127:89-94.
34. Strain EC, Preston KL, Liebson IA and Bigelow GE (1993) Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J Pharmacol Exp Ther 267: 624-634.
35. Thompson DM, Moerschbaecher JM and Winsauer PJ (1983) Drug effects on repeated acquisition: Comparison of cumulative and non-cumulative dosing. J Exp Anal Behav 39:175-184.
36. Wechsler D (1958) The Measurement and Appraisal of Adult Intelligence. Williams and Wilkins, Baltimore.
37. Wenger GR (1980) Cumulative dose-response curves in behavioral pharmacology. Pharmacol Biochem Behav 13:647-651.
38. Winger G, Palmer RK and Woods JH (1989) Drug-reinforced responding: Rapid determination of dose-response functions. Drug Alcohol Depend 24:135-142.
39. Woodhouse A, Hobbes AFT, Mather LE and Gibson M (1996) A comparison of morphine, pethidine and fentanyl in the postsurgical patient-controlled analgesia environment. Pain 64:115-121.
40. Wynn RL, Bergman SA, Rudo FG and Leventer M (1990) GABAmimetics diminish antinociception of meperidine under conditions which enhance other opioid μ-agonists. Arch Int Pharmacodyn Ther 304:136-146.
41. Zacny JP (1995) A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacology 3:432-466.
42. Zacny JP, Conley K and Galinkin J (1997a) Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther 282:1187-1197.
43. Zacny JF, Conley K and Marks S (1997b) Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. J Pharmacol Exp Ther 280:1-11.
44. Zacny JP, Hill JL, Black ML and Sadeghi P (1998) Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther 286:1197-1207.
45. Zacny JP, Lichtor JL, Binstock W, Coalson DW, Cutter T, Flemming DC and Glosten B (1993) Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers. Psychopharmacology 111:306-314.
46. Zacny JP, Lichtor JL, Flemming D, Coalson DW and Thompson WK (1994a) A dose-response analysis of the subjective, psychomotor, and physiological effects of intravenous morphine in healthy volunteers. J Pharmacol Exp Ther 268:1-9.
47. Zacny JP, Lichtor JL, Thapar P, Coalson DW, Flemming D and Thompson W (1994b) Comparing the subjective, psychomotor, and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther 270:579-588.
48. Zacny JP, Lichtor JL, Zaragoza JG and De Wit H (1992) Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology 107:319-326.